As for gene ANKRD34A (correlated with probes cg10178263, cg18280463, and cg13947666), according to related methylation studies (Giri and Aittokallio, 2018; Ding et al., 2020), such gene has shown to have methylation changes during the initiation and progression of multiple tumor subtypes, including lung, colon, bladder, lymphoma, breast and ovarian cancer. The gene discussed is ANKRD34A; the disease is ovarian cancer.